MBMichael H. Bonnet

Michael H. Bonnet

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael H. Bonnet has a total of 101 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Is slow-wave sleep the key to elevated blood pressure in insomnia patients?

    by Michael H Bonnet

    Michael H Bonnet; Is Slow Wave Sleep the Key to Elevated Blood Pressure in Insomnia Patients?, Sleep, , zsae259, https://doi.org/10.1093/sleep/zsae259

  • Pathophysiology of Insomnia

    by Michael H. Bonnet, Donna L. Arand


  • Insomnia

    by M.H. Bonnet, D.L. Arand

    Insomnia is the most common sleep disorder. A diagnosis of insomnia requires both a report of poor sleep at night and residual daytime impairment associated with the poor sleep. Insomnia is associated with many other medical problems ranging from depression to any issue that causes physical discomfort or pain. Insomnia may be associated with a specific set of environmental conditions or a chronic and unremitting problem that is either primary or associated with another medical problem. Treatment of an associated medical problem like pain improves sleep in some but not all cases. Conversely, treatment for insomnia may improve other medical outcomes. Primary insomnia seems to be related to inability to down regulate arousal and is frequently characterized by increased metabolic rate, heart rate, or other physiological markers. Some research has shown that insomnia may therefore be related to the development of hypertension and other disorders related to physiological arousal. Relatively little work has linked nutrition with insomnia. Beyond associations between caffeine or stimulant use and poor sleep, there is limited work linking poor nutrition with poor sleep and improved nutrition with better sleep.


  • Utility of caffeine: evidence from the laboratory

    by Michael H. Bonnet, Donna L. Arand

    The logic behind sleep deprivation studies is basically sound. The first problem is that sleep is a process that not only occurs in the brain, but is also a process that undoubtedly confers unique benefits to the brain itself. In the parlance familiar to those who are afflicted with a degree in experimental psychology and have thus been subjected to a course in "The Philosophy of Science", the scientific paradigm under which sleep deprivation research is conducted contains some conceptual gaps. The difficulty is as follows: extended continuous wakefulness is an antecedent condition that leads to a predictable, observable outcome: decremented performance. Results from studies conducted to determine the effects of sleep loss on various neurocognitive abilities have proven useful for informing policy, and decision-making in a variety of operational and regulatory environments, and the utilitarian value of such studies for testing work/rest schedules and drug effects remains high.


  • Sleep Deprivation, Stimulant Medications, and Cognition

    by Nancy J. Wesensten, Donna L. Arand, Thomas J. Balkin, Michael H. Bonnet, Tina M. Burke, Christina E. Carvey, Michael W. L. Chee, Emma Childs, Nicholas Davenport, Janine M. Hall-Porter, et al.

    Sleep Deprivation, Stimulant Medications, and Cognition provides a review, synthesis and analysis of the scientific literature concerning stimulant medications and neurobehavioral performance, with an emphasis on critically evaluating the practical utility of these agents for maintaining cognitive performance and alertness in sleep-deprived (but otherwise healthy) individuals. The book explores the nature of sleep loss-induced cognitive deficits, neurophysiologic basis of these deficits, relative efficacy and limitations of various interventions (including non-pharmacological), and implications for applying these interventions in operational environments (commercial and military). Readers of this volume will gain a working knowledge of: • Mechanisms contributing to sleep loss-induced cognitive deficits • Differential effects of stimulant compounds on various aspects of cognition • Considerations (such as abuse liability) when applying stimulant interventions in operational settings • Current state and future directions for including stimulants in comprehensive fatigue-management strategies. This text is key reading for researchers and trainees in sleep and psychopharmacology.


  • Objective measures of sleepiness

    by Michael H. Bonnet, Donna L. Arand

  • Sleepiness

    by Michael J. Thorpy, Michel Billiard, Brian Abaluck, Imran M. Ahmed, Torbjörn Åkerstedt, Sonia Ancoli-Israel, Anna Anund, Donna L. Arand, Isabelle Arnulf, Fiona C. Baker, et al.

    Written and edited by leading clinicians and researchers in sleep medicine, this is the first book to focus on the causes, consequences and treatment of disorders of excessive sleepiness. Extensive coverage is provided for all known causes of sleepiness, including sleep deprivation, obstructive sleep apnea syndrome, narcolepsy and other hypersomnias of central origin, shift work, and medical and psychiatric disorders. Since many causes of sleepiness are difficult to differentiate from each other, and treatment modalities can vary greatly from one disorder to another, this book helps the clinician to formulate a differential diagnosis that will ultimately lead to the correct diagnosis. Epidemiology, evaluation of the sleepy patient, diagnostic investigations including neuroimaging, subjective and objective testing, cognitive effects of sleepiness, motor vehicle driving issues, medico-legal aspects of sleepiness, and therapy are also discussed in detail. This is an essential resource for neurologists, psychiatrists and sleep specialists.


  • Hyperarousal and insomnia

    by Michael H. Bonnet


  • Top Cited Papers

    Hyperarousal and insomnia: State of the science

    by Michael H. Bonnet, Donna L. Arand